BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Ipsen Announces Its Corporate Agenda for 2018

  Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and specialty care.

  December 6, 2017

   · 

  2 min read
• Business

  High Point Clinical Trials Center Appoints Clayton Dehn, M.S. as Vice President of Clinical Pharmacology Services

  Clayton will lead Clinical Pharmacology Services and act as the Subject Matter Expert in the Metabolic Sciences offering at HPCTC.

  December 6, 2017

   · 

  3 min read
• Drug Development

  ITM: Enrollment of First Gastroenteropancreatic-Neuroendocrine Tumor (GEP-NET) Patient in Europe for the COMPETE Phase III Clinical Trial With N.C.A.177Lu-Edotreotide (Solucin)

  The study will be conducted predominantly in Europe, North America, South Africa and Australia. The first patient to be enrolled and treated was in Australia.

  December 6, 2017

   · 

  2 min read
• Sarah Cannon to Present Latest in Blood Cancer Research at the 59th Annual American Society of Hematology Meeting & Exposition

  Sarah Cannon announced that 28 abstracts authored by members of the Sarah Cannon Blood Cancer Network have been selected by the American Society of Hematology (ASH) for presentation at the upcoming 2017 Annual Meeting & Exposition.

  December 6, 2017

   · 

  3 min read
• Drug Development

  Madrigal’s MGL-3196 Achieves Primary Endpoint in Patients With Biopsy-Proven Non-alcoholic Steatohepatitis (NASH) in Phase II Clinical Trial

  In this trial, MGL-3196 demonstrated statistically significant results for the primary endpoint.

  December 6, 2017

   · 

  9 min read
• Novo Nordisk: Interim Results of First-Ever Global Survey Show People With Type 2 Diabetes Underestimate Their Cardiovascular Risk

  The global survey - Taking Diabetes to Heart - developed in partnership with Novo Nordisk, runs until March 2018 and is open to all people with type 2 diabetes.

  December 6, 2017

   · 

  5 min read
• Genetown

  Santhera Pharmaceuticals, Summit Therapeutics, Catabasis Pharmaceuticals and Duchenne UK to host Duchenne Muscular Dystrophy Awareness Day

  The half-day event will feature presentations by key opinion leaders representing clinical practitioners, industry professionals and the patient group Duchenne UK.

  December 6, 2017

   · 

  4 min read
• Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2017

  As of November 30, 2017, shares and voting rights outstanding of Essilor, the world leader in ophthalmic optics, broke down as follows:

  December 6, 2017

   · 

  1 min read
• Biotech Bay

  Kalytera Confirms No Material Change in Operations

  The company confirms that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity.

  December 6, 2017

   · 

  4 min read
• Data MATRIX Starts Projects in USA And Europe

  Data MATRIX team is about to start two new projects in the United States and Europe.

  December 6, 2017

   · 

  1 min read